JIEMX Performance — Equity Income Fund, Class 1
Data updated: 2026-09-24
JIEMX returned +11.67% year to date and +23.71% over one year to May 2026. Annualised returns are +17.28% over 3 years and +9.15% over 5 years. The fund beat its US Multi-Cap Value category average: $100 invested three years ago grew to $161, against $151 for the category, and to $124 over one year, against $117. Volatility over the past three years was 12.69% a year. In the 12 months to May 2026 the fund took in a net $373.0M, and assets reached $596.80M.
JIEMX Growth of $100
What $100 invested in Equity Income Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Multi-Cap Value category average over the same months.
| Period | JIEMX | Category average |
|---|---|---|
| 1 year (Jun 2025 – May 2026) | $124 | $117 |
| 3 years (Jun 2023 – May 2026) | $161 | $151 |
| 5 years (Jun 2021 – May 2026) | $155 | $144 |
| Since data start (Sep 2019 – May 2026) | $211 | $192 |
JIEMX Trailing Returns
Total returns to May 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +11.67% |
| 1 year | +23.71% |
| 3 years (annualised) | +17.28% |
| 5 years (annualised) | +9.15% |
JIEMX Annual Returns
Calendar-year total returns of Equity Income Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–May) | +11.67% |
| 2025 | +13.73% |
| 2024 | +11.64% |
| 2023 | +9.41% |
| 2022 | −3.46% |
| 2021 | +25.42% |
| 2020 | +1.09% |
| 2019 (Sep–Dec) | +10.95% |
JIEMX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +3.7% | +2.6% | −5.1% | +7.9% | +2.5% | — | — | — | — | — | — | — |
| 2025 | +4.6% | +1.0% | −1.6% | −4.9% | +3.9% | +2.8% | −0.8% | +4.2% | +0.4% | −0.4% | +2.1% | +2.2% |
| 2024 | −0.2% | +4.0% | +4.8% | −3.0% | +3.5% | −1.3% | +3.9% | +2.1% | +0.7% | −1.3% | +4.9% | −6.4% |
| 2023 | +5.5% | −3.7% | −2.3% | +2.1% | −5.2% | +6.5% | +4.1% | −3.9% | −3.3% | −2.6% | +7.4% | +5.5% |
| 2022 | +1.0% | −0.1% | +1.6% | −5.4% | +3.0% | −8.4% | +5.1% | −1.8% | −9.4% | +10.3% | +6.6% | −4.1% |
| 2021 | −0.4% | +6.6% | +6.7% | +4.0% | +2.8% | −2.4% | −0.6% | +2.3% | −2.6% | +4.4% | −3.6% | +6.5% |
| 2020 | −3.0% | −10.3% | −17.9% | +9.6% | +2.8% | +0.6% | +3.9% | +3.2% | −3.8% | −0.4% | +16.4% | +4.3% |
| 2019 | — | — | — | — | — | — | — | — | +3.8% | +0.5% | +3.3% | +2.9% |
JIEMX Risk
Risk measures from monthly returns over Jun 2023 – May 2026.
- 3-year volatility (annualised): 12.69%
- 3-year Sharpe ratio: 1.01 (vs 4.5% risk-free rate)
- Best month: +7.94% (Apr 2026)
- Worst month: −6.41% (Dec 2024)
JIEMX Fund Flows
Monthly money in and out of Equity Income Fund, from SEC Form N-PORT.
- 12-month net flow: $373.0M
- 12-month gross sales (incl. reinvestments): $509.3M
- Sales ÷ redemptions: 3.74×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| May 2026 | $1.0M | $11.4M | −$10.4M |
| Apr 2026 | $3.1M | $9.0M | −$5.9M |
| Mar 2026 | $2.7M | $7.9M | −$5.2M |
| Feb 2026 | $1.9M | $10.9M | −$9.1M |
| Jan 2026 | $2.2M | $17.1M | −$14.9M |
| Dec 2025 | $208.7M | $20.3M | $188.5M |
| Nov 2025 | $883K | $13.5M | −$12.6M |
| Oct 2025 | $1.8M | $14.0M | −$12.1M |
| Sep 2025 | $1.9M | $7.6M | −$5.6M |
| Aug 2025 | $1.7M | $9.1M | −$7.4M |
| Jul 2025 | $281.0M | $9.1M | $271.9M |
| Jun 2025 | $2.4M | $6.6M | −$4.2M |
JIEMX Assets Under Management
Net assets of Equity Income Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-05-31 | $596.80M |
| 2026-02-28 | $591.29M |
| 2025-11-30 | $584.28M |
| 2025-08-31 | $603.59M |
| 2025-05-31 | $318.09M |
| 2025-02-28 | $1.67B |
| 2024-11-30 | $1.80B |
| 2024-08-31 | $1.77B |
| 2024-05-31 | $1.72B |
| 2024-02-29 | $1.71B |
| 2023-11-30 | $1.61B |
| 2023-08-31 | $1.73B |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.